We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.8M
1-Year Est. Return 25.68%
This Fund
S&P 500
This Quarter Est. Return
+108.31%
1 Year Est. Return
+25.68%
3 Year Est. Return
+152.12%
5 Year Est. Return
+4.79%
10 Year Est. Return
–
AUM
$66.7M
AUM Growth
+$24.9M
Cap. Flow
-$11.9M
Cap. Flow %
-17.79%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$602M
$55.9M 83.77%
11,503,294
– –
DNLI icon
2
Denali Therapeutics
DNLI
$3.87B
$10.8M 16.23%
448,035
-505,000
-53% -$11.9M

Similar funds

GC
Gruss & Co West Palm Beach, Florida $40.8M AUM 44% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
CIC
Cincinnati Indemnity Company Fairfield, Ohio $41.1M AUM 6.63% 1-Year Est. Return
FC
Fiduciary Counselling Saint Paul, Minnesota $40.6M AUM 9.32% 1-Year Est. Return
AP
Atairos Partners Bryn Mawr, Pennsylvania $41.1M AUM 4.36% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $40.5M AUM 5.55% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $41.5M AUM 245.82% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Bratton Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Bratton Capital Management held 2 positions worth $66.7M, up 59% from $41.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bratton Capital Management withdrew a net $11.9M in Q2 2020, reducing 1 holding. Its largest reduction was Denali Therapeutics, cutting an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Bratton Capital Management's biggest Q2 2020 reduction was Denali Therapeutics, cutting an estimated $11.9M.
  • Bratton Capital Management's ten largest holdings make up 100% of its $66.7M portfolio in Q2 2020.
  • Bratton Capital Management opened 0 new positions and closed 0 in Q2 2020.
  • Bratton Capital Management's portfolio value rose 59% quarter-over-quarter to $66.7M.

Based on Bratton Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.